Abernethy Matt

Neurocrine Biosciences Inc.

Chief Financial Officer

Avg. Two Year Performance

No Purchase Track Record

(< 1%) Avg. Sale Return 0% Compound

Holdings: 31.53K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions